NPPES file of Aug 9, 2026

Hema Madhavi Vankayala, MD

Hematology & Oncology Physician · Fleming Island, FL

Hema Madhavi Vankayala, MD is a hematology & oncology physician with a practice address in Fleming Island, Florida, and NPI 1023227691, issued on May 21, 2007. Check the license (Florida ME132894, as entered in NPPES) on the Florida health license search; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1023227691
Name
Hema Madhavi Vankayala
Credential
MD
Primary taxonomy
Hematology & Oncology Physician 207RH0003X
License numbers
ME132894 FL
4301084093 MI
Self-reported in NPPES; status is on the state search
Practice location
2370 Market Dr, Fleming Island, FL 32003
Phone
(904) 264-6201
Enumerated
May 21, 2007
Record last updated
Jul 21, 2022
Fax
(904) 264-6858
Medicaid ID
021329800 FL
Medicare enrollment
Enrolled (PECOS I20170731001466); accepts Medicare assignment
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 2370 Market Dr

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Stacie Anderson, LCSWClinical Social Worker1386167229
  2. Christine Bang, M.D.Radiation Oncology Physician1699824946
  3. Brian Deegan, MDRadiation Oncology Physician1639513757
  4. Aria Gibbons, PAPhysician Assistant1902114408
  5. Mehdi Moezi, MDHematology & Oncology Physician1053316190
  6. Satish Shanbhag, MD,MPHHematology & Oncology Physician1215140454

Verify Hema Madhavi Vankayala in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersFlorida health license search
    Search for license ME132894
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Florida license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

15% more Medicare Part D claims than the average hematology & oncology physician in 2024

1,011 Medicare Part D claims for 164 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 26% of claims. 87 claims were for opioids.

  1. Hema Vankayala1,011
  2. Specialty average877

Most prescribed

  1. Eliquis76 claims
  2. Olanzapine62 claims
  3. Ondansetron Hcl44 claims
  4. Gabapentin42 claims
  5. Letrozole42 claims
  6. Prochlorperazine Maleate32 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The MIPS final score for 2023 (Medicare payment program): 99.7 of 100

The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualitynot scored (reweighted)
  2. Costnot scored (reweighted)
  3. Promoting interoperabilityout of 100 · 25%95.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $808.41

54 payments; by number, the most common kind was food and beverage; the largest payer was Novartis Pharmaceuticals Corporation. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Hema Vankayala$808.41
  2. Specialty average$7,481.41

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. Cancer Specialists LLCFleming Island, FL

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Hema Madhavi Vankayala among 818 hematology & oncology physician records in Florida

Hema Madhavi Vankayala, MD is one of 818 hematology & oncology physician records with a practice address in Florida. 84% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 46% of them.

  • NPI issued2007 · 46% of these records are older, 44% newer
  • In a Medicare fileYes · 84% of these records are
  • In the CMS Doctors and Clinicians fileYes · 71% of these records are
  • Graduated2000 · median 2003 among the 581 with a school on file
  • Record last updated2022 · 52% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Florida practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

5 hematology & oncology physician records list a practice address in Fleming Island

They are 5 of the 571 NPPES records with a practice address in Fleming Island, and 818 hematology & oncology physician records in Florida.

The 8 hematology & oncology physician records with the nearest ZIP codes

  1. Shane Clark, DOFleming Island, FL 320031902391477
  2. Yi Luo, M.D.Fleming Island, FL 320031528697265
  3. Mehdi Moezi, MDFleming Island, FL 320031053316190
  4. Satish Shanbhag, MD,MPHFleming Island, FL 320031215140454
  5. Dimitrios Agaliotis, MDFernandina Beach, FL 320341790764272
  6. Mathew Luke, MDFernandina Beach, FL 320341790772044
  7. William Peters, MD, PH.DAmelia Island, FL 320341316272511
  8. Amber Feinman, AMBER FEINMAN, D.O.Middleburg, FL 320681538432232

Common questions

What is Hema Madhavi Vankayala, MD's NPI number?

Hema Madhavi Vankayala, MD's National Provider Identifier (NPI) is 1023227691, issued on May 21, 2007. An NPI identifies a provider in billing; it is not a license.

Where is Hema Madhavi Vankayala, MD located?

The NPPES record lists a practice address at 2370 Market Dr, Fleming Island, FL, 32003. Phone: (904) 264-6201. Providers update this record themselves, so call before visiting.

How can I verify Hema Madhavi Vankayala, MD's license?

NPPES lists Florida license number ME132894, as entered by the provider. Search the Florida health license search at https://mqa-internet.doh.state.fl.us/mqasearchservices/healthcareproviders. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Hema Madhavi Vankayala, MD prescribe under Medicare Part D?

In 2024, Hema Madhavi Vankayala, MD had 1,011 Medicare Part D claims for 164 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.

What is Hema Madhavi Vankayala, MD's MIPS final score?

The 2023 MIPS final score is 99.7 of 100. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.